Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

1.

[Vaccination against HPV-associated neoplasias].

Gross G, Becker N, Brockmeyer NH, Esser S, Freitag U, Gebhardt M, Gissmann L, Hillemanns P, Grundhewer H, Ikenberg H, Jessen H, Kaufmann A, Klug S, Klussmann JP, Nast A, Pathirana D, Petry KU, Pfister H, Röllinghof U, Schneede P, Schneider A, Selka E, Singer S, Smola S, Sporbeck B, von Knebel Doeberitz M, Wutzler P.

Laryngorhinootologie. 2014 Dec;93(12):848-56. doi: 10.1055/s-0034-1382013. Epub 2014 Dec 1. German. No abstract available.

PMID:
25437625
2.

Rates of cardiovascular events and deaths are associated with advanced stages of HIV-infection: results of the HIV HEART study 7, 5 year follow-up.

Esser S, Eisele L, Schwarz B, Schulze C, Holzendorf V, Brockmeyer NH, Hower M, Kwirant F, Rudolph R, Neumann T, Reinsch N.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19542. doi: 10.7448/IAS.17.4.19542. eCollection 2014.

3.

[Increase of N. gonorrhoeae, Chlamydia trachomatis and Ureaplasma in HIV infected individuals].

Fuchs W, Brockmeyer NH.

MMW Fortschr Med. 2014 Jun 12;156 Suppl 1:48-50; quiz 51. Review. German. No abstract available.

PMID:
25026858
4.

Sexually transmitted infections.

Fuchs W, Brockmeyer NH.

J Dtsch Dermatol Ges. 2014 Jun;12(6):451-63. doi: 10.1111/ddg.12310. Review.

5.

Similar appearance, different mechanisms: xerosis in HIV, atopic dermatitis and ageing.

Mischo M, von Kobyletzki LB, Bründermann E, Schmidt DA, Potthoff A, Brockmeyer NH, Havenith M.

Exp Dermatol. 2014 Jun;23(6):446-8. doi: 10.1111/exd.12425.

PMID:
24758518
6.

[Off-label use and G-BA. Legal framework for off-label use].

Brucklacher U, Brockmeyer NH, Riedel C.

Hautarzt. 2013 Oct;64(10):736-42. doi: 10.1007/s00105-013-2591-4. German.

PMID:
24150821
7.

Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066).

Thoden J, Potthoff A, Bogner JR, Brockmeyer NH, Esser S, Grabmeier-Pfistershammer K, Haas B, Hahn K, Härter G, Hartmann M, Herzmann C, Hutterer J, Jordan AR, Lange C, Mauss S, Meyer-Olson D, Mosthaf F, Oette M, Reuter S, Rieger A, Rosenkranz T, Ruhnke M, Schaaf B, Schwarze S, Stellbrink HJ, Stocker H, Stoehr A, Stoll M, Träder C, Vogel M, Wagner D, Wyen C, Hoffmann C; Deutsche AIDS Gesellschaft; Österreichische AIDS-Gesellschaft.

Infection. 2013 Sep;41 Suppl 2:S91-115. doi: 10.1007/s15010-013-0504-1. Epub 2013 Sep 14.

8.

Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis.

Jansen K, Haastert B, Michalik C, Guignard A, Esser S, Dupke S, Plettenberg A, Skaletz-Rorowski A, Brockmeyer NH.

BMC Infect Dis. 2013 Aug 10;13:372. doi: 10.1186/1471-2334-13-372.

9.

["Who knows Podoconiosis?" A dermatologic travel report].

Coenenberg J, Altmeyer P, Brockmeyer NH, Potthoff A.

Hautarzt. 2013 Aug;64(8):606-10. doi: 10.1007/s00105-013-2613-2. German. No abstract available.

PMID:
23907173
10.

Long-term gender-based outcomes for atazanavir/ritonavir (ATV/r)- containing regimens in treatment-experienced patients with HIV.

Svedhem-Johansson V, Pugliese P, Brockmeyer NH, Thalme A, Michalik C, Esser S, Barlet MH, Nakonz T, Jimenez-Exposito MJ.

Curr HIV Res. 2013 Jun;11(4):333-41.

11.

Pharmacokinetic and pharmacodynamic analysis of efavirenz dose reduction using an in vitro-in vivo extrapolation model.

Siccardi M, Almond L, Schipani A, Csajka C, Marzolini C, Wyen C, Brockmeyer NH, Boffito M, Owen A, Back D.

Clin Pharmacol Ther. 2012 Oct;92(4):494-502. doi: 10.1038/clpt.2012.61. Epub 2012 Jul 18.

PMID:
22805423
12.

Evaluation of mental status HIV-infected patients: implications for treatment.

Jin YH, Potthoff A, Xu J, Yu WJ, Liu K, Weng NC, Brockmeyer NH, Wu NP.

Curr HIV Res. 2012 Sep;10(6):546-51.

PMID:
22716106
13.

The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus.

Hahn AS, Kaufmann JK, Wies E, Naschberger E, Panteleev-Ivlev J, Schmidt K, Holzer A, Schmidt M, Chen J, König S, Ensser A, Myoung J, Brockmeyer NH, Stürzl M, Fleckenstein B, Neipel F.

Nat Med. 2012 Jun;18(6):961-6. doi: 10.1038/nm.2805.

14.

[HIV infection].

Potthoff A, Rasokat H, Brockmeyer NH.

Hautarzt. 2012 Jan;63(1):10-5. doi: 10.1007/s00105-011-2195-9. German.

PMID:
22212157
15.

Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS.

Liptrott NJ, Pushpakom S, Wyen C, Fätkenheuer G, Hoffmann C, Mauss S, Knechten H, Brockmeyer NH, Hopper-Borge E, Siccardi M, Back DJ, Khoo SH, Pirmohamed M, Owen A; German Competence Network for HIV/AIDS.

Pharmacogenet Genomics. 2012 Jan;22(1):10-9. doi: 10.1097/FPC.0b013e32834dd82e.

16.

Pericardial effusion of HIV-infected patients ? Results of a prospective multicenter cohort study in the era of antiretroviral therapy.

Lind A, Reinsch N, Neuhaus K, Esser S, Brockmeyer NH, Potthoff A, Pankuweit S, Erbel R, Maisch B, Neumann T.

Eur J Med Res. 2011 Nov 10;16(11):480-3.

17.

Study of T cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAART.

Shou C, Weng N, Jin Y, Feng L, Jin C, Hoextermann S, Potthoff A, Skaletz-Rorowski A, Brockmeyer NH, Wu N.

Eur J Med Res. 2011 Nov 10;16(11):473-9.

18.

The impact of highly active antiretroviral treatment on the blood profiles of patients with acquired immune deficiency syndrome.

Tang LL, Jin CZ, Wu LJ, Brockmeyer NH, Potthoff A, Wu NP.

J Int Med Res. 2011;39(4):1520-8.

PMID:
21986156
19.

Perianal basal cell carcinoma - unusual localization of a frequent tumor.

Kreuter A, Bechara FG, Stücker M, Brockmeyer NH, Altmeyer P, Wieland U.

J Dtsch Dermatol Ges. 2012 Jan;10(1):59-61. doi: 10.1111/j.1610-0387.2011.07801.x. Epub 2011 Sep 27.

PMID:
21951773
20.

Development of a novel monoclonal antibody to B7-H4: characterization and biological activity.

Qian Y, Shen L, Xu C, Wu Z, Brockmeyer NH, Altmeyer P, Wu N, Yao HP.

Eur J Med Res. 2011 Jul 25;16(7):295-302.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk